Imexpharm Corporation (HOSE:IMP)
53,100
-900 (-1.67%)
At close: Sep 18, 2025
Imexpharm Market Cap
Imexpharm has a market cap or net worth of 8.18 trillion as of September 18, 2025. Its market cap has increased by 24.07% in one year.
Market Cap
8.18T
Enterprise Value
8.04T
Revenue
2.42T
Ranking
n/a
PE Ratio
24.84
Stock Price
53,100.00
Market Cap Chart
Since April 2, 2007, Imexpharm's market cap has increased from 1.11T to 8.18T, an increase of 637.54%. That is a compound annual growth rate of 11.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 18, 2025 | 8,177.88B | 12.98% |
Dec 31, 2024 | 7,238.42B | 82.69% |
Dec 29, 2023 | 3,962.17B | -1.28% |
Dec 30, 2022 | 4,013.63B | -22.62% |
Dec 31, 2021 | 5,187.05B | 38.19% |
Dec 31, 2020 | 3,753.61B | 58.34% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition